-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Xenon Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2024.
- Xenon Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$3.85M, a 1777% decline year-over-year.
- Xenon Pharmaceuticals Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$4.09M, a 1300% decline year-over-year.
- Xenon Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2024 was -$4.09M, a 1300% decline from 2023.
- Xenon Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was -$292K, a 347% decline from 2022.
- Xenon Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $118K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)